The World Health Organisation (WHO) has reported significant progress in India's fight against tuberculosis (TB), noting an 18% decline in TB incidence from 2015 to 2023, compared to a global decline of 8%. The report highlights a 21% reduction in TB mortality and a substantial increase in the TB budget from Rs 640 crores in 2015 to Rs 3,400 crores in 2022-23. India is enhancing its TB diagnostic capabilities with AI-enabled x-ray machines and has introduced a new treatment regimen for Multidrug-Resistant Tuberculosis (MDR-TB). The number of notified TB patients has also increased by 4% in 2024.
The World Health Organisation (WHO) has reported significant progress in India's fight against tuberculosis (TB), noting an 18% decline in TB incidence from 2015 to 2023, compared to a global decline of 8%. The report highlights a 21% reduction in TB mortality and a substantial increase in the TB budget from Rs 640 crores in 2015 to Rs 3,400 crores in 2022-23. India is enhancing its TB diagnostic capabilities with AI-enabled x-ray machines and has introduced a new treatment regimen for Multidrug-Resistant Tuberculosis (MDR-TB). The number of notified TB patients has also increased by 4% in 2024.
•TB incidence in India declined by 18% from 2015 to 2023.
•Global TB incidence declined by only 8% during the same period.
•TB mortality in India reduced by 21%, from 28 to 22 per lakh population.
•TB budget increased from Rs 640 crores in 2015 to Rs 3,400 crores in 202223.
•India is procuring 800 AIenabled portable chest xray machines.
•Introduction of the BPaLM regimen for MultidrugResistant TB under NTEP.
•4% increase in notified TB patients in 2024 compared to 2023.